SAN
Santhera
Stock
Stock
ISIN: CH1276028821
Ticker: SANN
CH1276028821
SANN
Price
Price
CHART BY
Frequently asked questions
What is Santhera's market capitalization?
The market capitalization of Santhera is 176.20M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Santhera's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Santhera is 2.38. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Santhera?
Santhera's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $5.923. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Santhera's stock?
Currently, 2 analysts cover Santhera's stock, with a consensus target price of 22.50. Analyst ratings provide insights into the stock's expected performance.
What is Santhera's revenue over the trailing twelve months?
Over the trailing twelve months, Santhera reported a revenue of 113.59M.
What is the EBITDA for Santhera?
Santhera's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is 57.08M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Santhera?
Santhera has a free cash flow of 47.35M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Santhera have, and what sector and industry does it belong to?
Santhera employs approximately 45 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.
What is the free float of Santhera's shares?
The free float of Santhera is 9.63M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- 176.20M
- EPS (TTM)
- $5.923
- Free Float
- 9.63M
- P/E ratio (TTM)
- 2.38
- Revenue (TTM)
- 113.59M
- EBITDA (TTM)
- 57.08M
- Free Cashflow (TTM)
- 47.35M
Pricing
- 1D span
- $14.71$15.64
- 52W span
- $8.161$17.34
Analyst Ratings
The price target is 22.50 and the stock is covered by 2 analysts.
Buy
2
Hold
0
Sell
0
Information
Santhera Pharmaceuticals Holding AG engages in the development and commercialization of products for the treatment of neuromuscular and pulmonary diseases. Its product pipeline includes Vamorolone and Lonodelestat. The company was founded by Thomas Meier in 1998 and is headquartered in Pratteln, Switzerland.
- Employees
- 45
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- CH1276028821
- Primary Ticker
- SANN